Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection
Not Applicable
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- Manresana de Micobacteriologia, SL
- Target Recruit Count
- 24
- Registration Number
- NCT02581579
- Locations
- 🇪🇸
Germans Trias I Pujol Hospital, Badalona, Barcelona, Spain
🇪🇸Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
🇪🇸Valle Hebron Hospital, Barcelona, Spain
Safety and Immunogenicity of Nyaditum Resae® Probiotic to Protect From Tuberculosis
Not Applicable
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2014-03-03
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- Manresana de Micobacteriologia, SL
- Target Recruit Count
- 47
- Registration Number
- NCT02076139
- Locations
- 🇪🇸
Germans Trias I Pujol Hospital, Badalona, Barcelona, Spain
News
No news found